The migration pattern of lymphocytes labelled with indium-111 was followed in a patient with B cell nonHodgkin's lymphoma treated with a murine monoclonal anti-idiotype antibody. During the early phase of continuous infusion of antibody rapid fluxes of labelled lymphocytes into and out of the blood were seen. Dynamic scanning showed immediate uptake in the lungs; thereafter activity decreased in the lungs and increased in the liver. Studies of labelled and unlabelled cells in the circulation showed that treatment resulted in the removal of lymphocytes from the blood which was repopulated from an extravascular compartment. Tumour cells were shown to be cleared from the blood by the reticuloendothelial system in the liver.
Introduction
The migratory properties of cells in the blood may be studied by tagging the cells with a radiolabel in vitro and tracing the patterns of homing and recirculation of the labelled cells after reinjection.
The fate of radiolabelled lymphocytes has been studied in vivo in normal subjects,' in patients with lymphoma,' and in patients with chronic lymphocytic leukaemia. [3] [4] [5] [6] The earlier studies of lymphocyte kinetics used tritiated thymidine,3 cytidine labelled with tritium,5 6 or chromium-51 (as sodium chromate (51Cr))6 as the radiolabel.
The survival in the blood of reinjected tumour cells labelled with 51Cr and coated in vitro with monoclonal antibody Ab89 (which is directed against an antigen associated with lymphoma) was examined by Nadler et al. 7 Dillman et al used chromium-5 1 as a radiolabel to follow the effect of administration in vivo of monoclonal antibody T101 in two patients with chronic lymphocytic leukaemia. 8 Whereas chromium-5 1 is a useful tool for following the kinetics of blood lymphocytes, indium-l 1 may be used to follow the circulation and distribution of labelled lymphocytes by gammacamera imaging. Several workers have shown that indium-Ill oxine is a reliable radioactive label for studies in vivo of lymphocyte traffic.9 10 Miller et al used lymphocytes labelled with indium-I ll oxine to study the effect of a monoclonal antibody (L17F12) directed against a normal T cell differentiation antigen in a patient with T cell leukaemia."1
Here we report on a patient with advanced B cell nonHodgkin's lymphoma whom we treated with infusion of monoclonal anti-idiotype antibody. Autologous lymphocytes were reinjected, after labelling with indium-111, as infusion was started, and the changes in the migratory patterns of the malignant cells during treatment were followed.
Patient and method
A 71 year old woman with advanced, diffuse, poorly differentiated lymphocytic non-Hodgkin's lymphoma had widespread lymphadenopathy, bulk abdominal disease, ascites, and affected blood and bone marrow. The spleen had been removed 10 months before treatment began. She was treated with a monoclonal antibody directed against the immunoglobulin idiotype that was expressed on the malignant tumour cells (Rankin and Hekman, submitted for publication). The idiotype (the determinants of the immunoglobulin unique to each normal or malignant B cell clone) can be regarded as a tumour specific antigen and a possible target for immunotherapy.12 She was given a total of 3800 mg of the anti-idiotype antibody (designated T2) in our treat-1097 ment sessions over two months. In the present study the antibody was given as a continuous infusion at a rate of 75 mg/hour for two hours followed by 20 mg/hour for 40 hours.
Autologous lymphocytes, of which more than 80"' were tumour cells, were reinjected after labelling with indium-111, and the redistribution was assessed on two occasions with serial blood sampling and gammacamera imaging: on the first the migration pattern of 4x 108 labelled lymphocytes was followed; on the second we studied the fate of 6 x 108 labelled lymphocytes injected simultaneously with the start of infusion of monoclonal anti-idiotype antibody.
The 
Results
Blood disappearance curves- Figure 1 shows the rate of disappearance of the lymphocytes labelled with indium-l 11 oxine reinjected at a time when the patient was not receiving treatment. Initially, activity fell rapidly until 12 hours, when a secondary rise occurred followed by a more gradual decrease. Activity was still detectable at 1 18 hours. The disappearance curve for the period of treatment (fig 2) was very different. Rapid fluxes of cells into and out of the circulation occurred during the first six hours, after which activity stayed constant and low with a minor rise corresponding to the end of the infusion of the antibody. In contrast, counts in the plasma varied little, indicating that the cells were not being destroyed intravascularly. These fluxes in the circulation did not parallel the changes in the total number of lymphocytes in the blood (fig 3) . These fell from 20 7 x 109/1 to a nadir at Gammacamera images- Figure 4 shows some of the gammacamera images obtained when the patient was not being treated. retroperitoneal mass of nodes below the liver was delineated. Figure 5 shows dynamic scans taken during the first 30 minutes of infusion of antibody, and figure 6 shows serial scans taken at intervals thereafter. Infusion of the antibody through a cannula in the right superior vena cava began at the same time as the labelled lymphocytes were reinjected into the right arm. Considerable lung activity occurred at one minute. This decreased thereafter as the liver activity increased. By 18 minutes three hot spots were visible in the thorax; these corresponded to: the site of insertion of the long line; a right pleural effusion; and a mass of tumour measuring 5 x 6 cm in the left breast. At two hours the tumour in the mediastinum was visible, and by 18 hours uptake by bone marrow was apparent and activity in the retroperitoneal nodes could be seen. We found that treatment with a monoclonal anti-idiotype antibody, which was specific for the malignant tumour cells, resulted in a transient fall in the tumour cells in the circulation (Rankin and Hekman, submitted for publication). Only one report has previously been published of the use in vivo of a monoclonal anti-idiotype antibody, and in that case the patient did not have malignant lymphocytes in the blood.'4 Other workers have, however, found that treatment in vivo with antibodies directed against antigens on the tumour lymphocytes, including idiotype, resulted in rapid but transient falls in the circulating tumour cells.6 1015-18 It is crucially important to know whether the antibody is merely altering the circulation pathways of the cells by temporarily sequestering them in an extravascular compartment, from which they emerge near or after the end of treatment, or whether the cells are being removed altogether. If radiolabelled tumour cells are injected at the time antibody treatment begins their fate can be followed; if cells returning when the cell count rebounds during treatment do not carry the radiolabel they are new cells and not those that disappeared.
In the study reported here the patterns of lymphocyte circulation in the blood of our patient were radically altered during the infusion of anti-idiotype antibody. The lack of correlation between the blood disappearance curves during treatment (fig 2) and the changes in blood lymphocyte counts-a transient fall followed by a slow inexorable rise above the baseline count (fig 3) -suggests that the antibody permanently removed circulating tumour cells and that the circulation was repopulated by lymphocytes from an extravascular compartment. Evidence from the gammacamera images suggests that the cells that disappeared during treatment were cleared by the reticuloendothelial system in the liver. Thus the recirculation pathways were altered because the lymphocytes were destroyed.
Although indium-ill must be used circumspectly as it may cause chromosomal damage in labelled cells,'9 the studies described here serve to show its usefulness as a radiolabel for following the migration pathways of lymphocytes in vivo.
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ONE HUNDRED YEARS AGO
Another correspondent, writing from Assouan, on November 3rd, informs us that the expedition for the relief of General Gordon and of Khartoum, was, at that date, assembling at Assouan and Wady Halfa; and that, as steamers and trains were daily becoming disabled, it would be some time, he expected, before an advance to the front could be accomplished. Meanwhile, the following cheering notes respecting climate, food, prevailing diseases, and the sanitary aspects and surroundings of the expedition, will be read with interest. As regards climate, there had been, during October, a combination of hot days and comparatively cold nights. The Fahrenheit thermometer ranged from 930 or 950 in the day, down to 65°, or even 60°, at night; though, as a rule, the day-temperature seldom exceeded 890. There were very heavy night-dews, saturating the men's clothes; but, at this early period of the campaign, few, except night-sentries, were exposed to it. So long as the north wind blew, the days were not felt to be hot or oppressive; southerly or easterly winds, however, made the days sultry and stifling; but there was no appreciable illness to be attributed to the weather. At the date of the letter, in November, the climate was delightful. The temperature was always under 80°in the shade by day, with a fine strong north wind; whilst the nights were so cold (the mercury always standing then below 600) that flannel vests, jackets, and blankets, were necessary. The food issued to the troops had been, so far, good and plentiful, consisting of fresh beef, frequently supplied, potatoes, onions, melons, and gourds in abundance. The bread was good, quite different from that furnished to the troops during the campaign in 1882. The men could buy quantities of eggs, milk, poultry, dates and other fruits; and this remark was applicable to all the stations from Alexandria to Assouan. There were a number of cases of enteric fever of a severe type; asthenic, with high temperature. These existed chiefly among the young soldiers, mere lads, in some of the infantry regiments. Dysentery of an ordinary type prevailed, though not to a great extent. Cases of sunstroke were very rare; there had been a few instances amongst officers who had previously suffered from it, and whose military zeal had led them to return to Egypt from England too soon. Diarrhoea was mild and harmless, and prevailed among fresh arrivals. There were a few cases of mild conjunctivitis. Syphilis was very prevalent; the villages were "saturated" with it, and the troops were consequently restricted from entering them, except "on pass." All kinds ofsanitary precautions had been adopted to preserve the health of the men. Camp-filters, large vessels ("chatties"), and pocket-filters were in use by the troops. Bathing every morning was, if possible, accomplished; flannel shirts and flannel belts were worn; "goggles" and green veils could be used, if required; blankets and great-coats were supplied for use at night; tents were issued; and the dry earth latrines in deep trenches were situated well to leeward of the camp. There was an abundance of medicines and medical comforts, even for small parties of troops. The hospitals were well equipped, and had a good supply of mosquito-curtains and fly-flaps. A few nursing-sisters were up the country. Everything relating to the medical success of the expedition seemed now to depend upon transport. As our correspondent justly remarks, "Medical men cannot work without appliances." (British Medical JYournal 1884;ii :1034.)
